Table 1 Sociodemographic characteristics
|  | Placebo group (N = 10) | Olanzapine group (N = 15) |  | |
|---|---|---|---|---|
N | N | P-value | ||
Gender (%) | Â | Â | Â | 0.69 |
| Â | Male | 5 (50) | 6 (40) | Â |
| Â | Female | 5 (50) | 9 (60) | Â |
Diagnosis (%) | Â | Â | Â | 1.0 |
| Â | MDD | 5 (50) | 7 (47) | Â |
| Â | BD | 5 (50) | 8 (53) | Â |
Age (±SD) |  | 46 (9) | 46 (17) | 0.24 |
Weight (±SD) | Visit 1 | 185 (50) | 178 (36) | 0.76 |
| Â | Visit 4 | 185 (51) | 182 (37) | Â |